SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIZZOTTO, Lara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.273
AS - Asia 1.459
EU - Europa 980
SA - Sud America 189
AF - Africa 19
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.925
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.210
SG - Singapore 612
CN - Cina 464
DE - Germania 262
BR - Brasile 167
UA - Ucraina 149
IT - Italia 135
HK - Hong Kong 122
GB - Regno Unito 111
TR - Turchia 111
FI - Finlandia 71
VN - Vietnam 69
SE - Svezia 58
RU - Federazione Russa 54
CA - Canada 34
FR - Francia 31
MX - Messico 26
IN - India 20
BE - Belgio 19
CZ - Repubblica Ceca 19
ES - Italia 19
PL - Polonia 18
ID - Indonesia 15
ZA - Sudafrica 13
JP - Giappone 10
AR - Argentina 9
BD - Bangladesh 9
NL - Olanda 9
LT - Lituania 7
RO - Romania 6
AT - Austria 5
IQ - Iraq 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
PK - Pakistan 3
AU - Australia 2
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
CO - Colombia 2
KR - Corea 2
MA - Marocco 2
SA - Arabia Saudita 2
TW - Taiwan 2
UZ - Uzbekistan 2
CH - Svizzera 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SV - El Salvador 1
TH - Thailandia 1
TO - Tonga 1
TZ - Tanzania 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
Totale 5.925
Salva come PNG Salva come JPEG
Città #
Singapore 361
Woodbridge 358
Ashburn 323
Chandler 253
Fairfield 252
Beijing 198
Santa Clara 171
Jacksonville 170
Ann Arbor 150
Houston 150
Hong Kong 122
Seattle 112
Wilmington 100
Cambridge 97
Dallas 89
New York 78
Izmir 62
Munich 61
Los Angeles 60
Ferrara 49
Nanjing 42
Princeton 38
Shanghai 36
Boardman 33
Milan 31
Ho Chi Minh City 28
São Paulo 25
San Diego 23
Bremen 22
Brussels 19
Buffalo 19
Turku 19
Mexico City 18
Dearborn 17
Helsinki 17
London 17
Shenyang 17
Nanchang 16
Warsaw 16
Addison 15
Brno 15
Brooklyn 13
Changsha 13
Frankfurt am Main 13
Denver 12
Hanoi 12
Montreal 12
San Francisco 12
Stockholm 12
Tianjin 12
Johannesburg 11
Guangzhou 9
Jiaxing 9
Manchester 9
Orem 9
San Jose 9
Tokyo 9
Toronto 9
Zhengzhou 9
Falkenstein 8
Jakarta 8
Jinan 8
Moscow 8
Poplar 8
Auburn Hills 7
Chennai 7
Columbus 7
Dortmund 7
Hefei 7
Mountain View 7
Reynoldsburg 7
The Dalles 7
Atlanta 6
Chicago 6
Norwalk 6
Orange 6
Phoenix 6
Rio de Janeiro 6
Amsterdam 5
Bexley 5
Bologna 5
Falls Church 5
Washington 5
Augusta 4
Biên Hòa 4
Boston 4
Guarulhos 4
Lyon 4
Mumbai 4
Olomouc 4
Querétaro 4
Raleigh 4
Redwood City 4
Secaucus 4
Baghdad 3
Des Moines 3
Hebei 3
Kolkata 3
Maceió 3
Palhoça 3
Totale 4.112
Salva come PNG Salva come JPEG
Nome #
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 232
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 215
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 212
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 206
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 202
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 197
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 194
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 190
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 184
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 184
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 177
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients 177
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 171
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 169
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 169
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 158
Multiparametric flow cytometric characterization of circulating stem cell subsets in patients with myocardial infarction: correlation with clinical and biological data 157
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 154
The complete impairment of factor VII gene expression by the IVS6+1g/t mutation is compatible with a severe but not lethal bleeding disorder 154
Aberrant splicing reverts a potentially lethal coagulation deficiency caused by a +1g/t splicing mutation 153
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 144
Rescue of coagulation factor VII function by the U1+5A snRNA 143
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 143
Association of the homozygous nonsense mutation R402X in coagulation factor VII with asymptomatic phenotype 140
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 138
Intracellular evaluation of ER targeting elucidates a mild form of inherited coagulation deficiency 135
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 134
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 132
Non-conventional therapeutic strategies for inherited disorders of hemostasis 121
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 117
Diagnostic workup for clinical and prognostic assessment of acute leukemia. 99
The FVII R402X nonsense mutation, associated with an asymptomatic phenotype, is responsible for small amounts of circulating protein with improved coagulant activity 99
Rescue of coagulation factor VII mRNA processing and protein function by engineered U1+5A snRNA 98
null 94
Extended lifespan of normal human B lymphocytes experimentally infected by SV40 or transfected by SV40 large T antigen expression vector 88
Erratum to: Circulating endothelial cells in patients with chronic lymphocytic leukemia: Clinical-prognostic and biologic significance (Cancer (2010) 116, (1926-37)) 88
Naturally occurring truncated proteins: decreased protein secretion and increased activity result in asymptomatic coagulation factor deficiency 86
null 82
“Compensatory” aberrant splicing supports residual expression levels in severe coagulation factor VII deficiency 74
null 64
Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII 54
null 42
Totale 5.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.876
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021317 0 0 0 0 0 58 22 56 12 53 81 35
2021/2022442 38 55 27 10 29 18 16 21 9 34 50 135
2022/2023524 49 52 8 80 96 68 28 44 66 2 22 9
2023/2024233 25 26 9 3 12 50 9 12 8 6 3 70
2024/2025986 14 24 73 45 137 107 9 22 162 91 142 160
2025/20261.597 333 113 242 380 468 61 0 0 0 0 0 0
Totale 5.970